Daniele Caracciolo

6PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 29, 2025
Impact of COVID-19 on Hematologic Cancer Patients: Insights From the Late Pandemic Phase.

Daniele Caracciolo, Giuseppe D'Aquino, Caterina Froio

|Nov 14, 2023
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma.

Daniele Caracciolo, Nicoletta Polerà, Beatrice Belmonte

|Feb 18, 2021
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia.

Daniele Caracciolo, Caterina Riillo, Andrea Ballerini

|Oct 22, 2020
Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice.

Mariamena Arbitrio, Francesca Scionti, Maria Teresa Di Martino

|May 09, 2020
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment.

Daniele Caracciolo, Caterina Riillo, Mariamena Arbitrio

Pageof 1